The past year has provided an extraordinary opportunity for founders, investors, and healthcare experts to partner together to develop solutions that sit at the intersection of healthcare and digital technology. That partnership has propelled the industry forward with innovative, urgently needed solutions to remediate the vulnerabilities exposed by the global pandemic. It also has accelerated the evolution from a “sick care” system to a resilient, proactive Health Assurance system designed to help people stay well, bend the cost curve, and make quality care more affordable and more accessible to all.
Today, we announce the launch of General Catalyst’s $600M Health Assurance Fund. This new fund is a key component of a comprehensive Health Assurance offering that includes our Stakeholder Aligned Initial Listings (SAIL) — Health Assurance Acquisition Corporation (HAAC) and Revolution Healthcare Acquisition Corporation. Dedicated to empowering founders and companies in both the private and public markets, this offering will accelerate the transformation of the healthcare industry into an equitable system of Health Assurance in service of a healthier society.
Through the Health Assurance Fund, General Catalyst will continue to create and invest in high impact, high return companies committed to delivering the promise of Health Assurance. That includes favoring partnerships over pure disruption, and empowering consumers with technology and experiences that both inform and delight, while honoring privacy and protecting data. These companies have critical work ahead that impacts us all: modernizing the healthcare ecosystem to create efficiencies and cost savings and improve clinical outcomes; alleviating the burdensome administrative and technological roadblocks that prevent doctors and nurses from doing what they do best; and aligning performance and the interests of patients, providers, and greater society.
Specifically, as investors and company creators, we have seen tremendous opportunity to address these challenges through digital health focused on: home hospital care; software infrastructure workforce transformation tools for care providers; payments and insurance; pharma software; women’s health; and diagnostics. Our Health Assurance Fund enables us to continue to create and proactively support stand-out companies in these areas from seed to growth stage and beyond, while managing our concentration in Health Assurance companies across our current set of active funds.
While the transformation to a system of Health Assurance is underway, it will not happen overnight, nor will it happen without working through the existing healthcare infrastructure. We fundamentally believe that the greatest change will come from a partnership between new companies that embrace a software-driven, change-the-world, maker’s mentality and the experience, empathy, and vision of health system leaders. In fact, our Health Assurance platform is built on this model of radical collaboration: our new fund is supported by Limited Partners representing some of the most-respected healthcare organizations in the industry. And, our extended healthcare team is comprised of experienced tech, investment, and healthcare experts both in the U.S. and abroad, including our new Endurance Partners-in-Residence. This team will work together to identify and create the enduring companies that will transform the industry into a more proactive, resilient, and equitable system of care. That is the potential and promise of Health Assurance. The opportunity is now.
This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities and funds are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Nothing in this post, this blog, this site, or any General Catalyst post or site should be construed in any way as an offer to sell or purchase securities or any other investment, nor should any of our content, in part or in whole, be construed as an investment recommendation of any kind. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by General Catalyst, or any security issued by any company, fund, or entity affiliated with or sponsored by General Catalyst. (An offering to invest in a General Catalyst fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.)
Any investments, securities, companies, funds, or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by General Catalyst, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by General Catalyst (excluding investments for which the issuer has not provided permission for General Catalyst to disclose publicly) is available at https://www.generalcatalyst.com/portfolio/.